価格表

在庫・価格 : 2024年05月06日 13時08分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Urotensin II, Human, EIA Kit (96 well)
データシート※最新のデータシートでない場合があります
EK-071-05 PPEフェニックス ファーマシューティカルス
Phoenix Pharmaceuticals, Inc.
1 kit ¥167,000
(未発注)
追加

在庫・価格 : 2024年05月06日 13時08分 現在

Urotensin II, Human, EIA Kit (96 well)

  • 商品コード:EK-071-05
  • メーカー:PPE
  • 包装:1kit
  • 価格: ¥167,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Watanabe T et al. Human urotensin II accelerates foam cell formation in human monocyte-derived macrophages. Hypertension 2005 Oct;46(4):738-44
Watanabe T et al
2005/01/01
PubMed
2 Rdzanek A et al. Exercise urotensin II dynamics in myocardial infarction survivors with and without hypertension. Int. J. Cardiol. 2006 Jun;110(2):175-8
Rdzanek A et al
2006/01/01
PubMed
3 Mallamaci F et al. Urotensin II and biomarkers of endothelial activation and atherosclerosis in end-stage renal disease. Am. J. Hypertens. 2006 May;19(5):505-10
Mallamaci F et al
2006/01/01
PubMed
4 Suguro T et al. Increased human urotensin II levels are correlated with carotid atherosclerosis in essential hypertension. Am. J. Hypertens. 2007 Feb;20(2):211-7
Suguro T et al
2007/01/01
PubMed
5 Ravani P et al. Urotensin II is an inverse predictor of death and fatal cardiovascular events in chronic kidney disease. Kidney Int. 2008 Jan;73(1):95-101
Ravani P et al
2008/01/01
PubMed
6 Zoccali C et al. Urotensin II and cardiomyopathy in end-stage renal disease. Hypertension 2008 Feb;51(2):326-33
Zoccali C et al
2008/01/01
PubMed
7 Suguro T et al. Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes. Clin. Sci. 2008 Dec;115(11):327-34
Suguro T et al
2008/01/01
PubMed
8 Bicak U et al. Possible pathogenic link between migraine and urotensin-II. J. Child Neurol. 2008 Nov;23(11):1249-53
Bicak U et al
2008/01/01
PubMed
  • No.: 1
  • 文献情報:
    Watanabe T et al. Human urotensin II accelerates foam cell formation in human monocyte-derived macrophages. Hypertension 2005 Oct;46(4):738-44
    Watanabe T et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Rdzanek A et al. Exercise urotensin II dynamics in myocardial infarction survivors with and without hypertension. Int. J. Cardiol. 2006 Jun;110(2):175-8
    Rdzanek A et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Mallamaci F et al. Urotensin II and biomarkers of endothelial activation and atherosclerosis in end-stage renal disease. Am. J. Hypertens. 2006 May;19(5):505-10
    Mallamaci F et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Suguro T et al. Increased human urotensin II levels are correlated with carotid atherosclerosis in essential hypertension. Am. J. Hypertens. 2007 Feb;20(2):211-7
    Suguro T et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Ravani P et al. Urotensin II is an inverse predictor of death and fatal cardiovascular events in chronic kidney disease. Kidney Int. 2008 Jan;73(1):95-101
    Ravani P et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Zoccali C et al. Urotensin II and cardiomyopathy in end-stage renal disease. Hypertension 2008 Feb;51(2):326-33
    Zoccali C et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Suguro T et al. Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes. Clin. Sci. 2008 Dec;115(11):327-34
    Suguro T et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Bicak U et al. Possible pathogenic link between migraine and urotensin-II. J. Child Neurol. 2008 Nov;23(11):1249-53
    Bicak U et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed